HYOU1 and COVID-19: This study aimed to quantify antiHCII, antiAPOA1, antiCUBN, antiXPNPEP2, anti-ORP150, and antiCREB3L3 levels in both urine and serum samples from moderate and severe COVID-19 patients, followed by multiple binomial regression modeling and estimation of the diagnostic value of the multiplex model.